Cleared Traditional

K920664 - DIAGNOSTIC ULTRASOUND/URO-GYN UPS 2020, GI VERSION (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K920664 · Diagnostic Ultrasound Corp. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
679d
Days
Class 2
Risk

K920664 is an FDA 510(k) clearance for the DIAGNOSTIC ULTRASOUND/URO-GYN UPS 2020, GI VERSION. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Diagnostic Ultrasound Corp. (Kirkland, US). The FDA issued a Cleared decision on December 23, 1993 after a review of 679 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Diagnostic Ultrasound Corp. devices

Submission Details

510(k) Number K920664 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1992
Decision Date December 23, 1993
Days to Decision 679 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
549d slower than avg
Panel avg: 130d · This submission: 679d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 68
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K920664.
mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001)
K252605 · Medspira, LLC · Dec 2025
Solar Compact (G4-1)
K240007 · Laborie Medical Technologies, Corp. · May 2024
EndoflipTM 300 System
K231861 · Covidien, LLC · Jul 2023
EndoflipTM 300
K223705 · Covidien, LLC · Apr 2023
Transit-Pellets
K222000 · Medifactia AB · Jan 2023